Adverse drug event reporting system to be streamlined

Published: 2013-01-29 06:58:00

Updated: 2013-01-29 06:58:00

The Korea Food and Drug Administration (KFDA) said last Friday that all of adverse drug events (ADEs), including the ones reported during the drug re-examination period, will be solely handled by the Korea Institute of Drug Safety & Risk Management (KIDS) as part of efforts to streamline the nati...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK